Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia
Phase 1/2 clinical trial of EDIT-401 cleared to initiate dosing in patients who require additional LDL-C loweringCompany remains on track to begin patient dosing this year and report initial safety and tolerability data in the first quarter of 2027New EDIT-401 preclinical data demonstrating durabil…